A multicenter study of apheresis collection of peripheral blood mononuclear (PBMC) in patients with CD19 expressing malignancies who could be eligible for a CTL019 clinical research trial

Administered By

Awarded By

Contributors

Start/End

  • April 1, 2015 - December 31, 2020